Oncopeptides drug candidate crosses blood — brain barrier in glioblastoma study
Oncopeptides presented new results on Oct. 9 from its Insula study in glioblastoma, an aggressive form of brain cancer. The drug candidate crossed the blood-brain barrier and reached tumor tissue as expected. Patients have tolerated the candidate well so far. Disclaimer: This news brief was created by Public Technologi